Related Experiment Video
Updated: Nov 26, 2025

08:52
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.4K
Iris Metastasis Regression Following Osimertinib Treatment
Kuan-Jen Chen1,2, An-Ning Chao1,2, Chih-Liang Wang2,3
1Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
JAMA Ophthalmology
|December 10, 2020
Abstract
No abstract available in PubMed .

